Lysosomal pH-inducible supramolecular dissociation of polyrotaxanes possessing acid-labile N-triphenylmethyl end groups and their therapeutic potential for Niemann-Pick type C disease

References

• Luzio JP , Pryor PR , Bright NA . Lysosomes: fusion and function. Nat Rev Mol Cell Biol. 2007;8:622–632.10.1038/nrm2217
   PubMed Web of Science ®Google Scholar
• Saftig P , Klumperman J . Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function. Nat Rev Mol Cell Biol. 2009;10:623–635.10.1038/nrm2745
   PubMed Web of Science ®Google Scholar
• Sancak Y , Bar-Peled L , Zoncu R , et al . Ragulator-rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell. 2010;141:290–303.10.1016/j.cell.2010.02.024
   PubMed Web of Science ®Google Scholar
• Futerman AH , van Meer G . The cell biology of lysosomal storage disorders. Nat Rev Mol Cell Biol. 2004;5:554–565.10.1038/nrm1423
   PubMed Web of Science ®Google Scholar
• Platt FM , Boland B , van der Spoel AC . Lysosomal storage disorders: the cellular impact of lysosomal dysfunction. J Cell Biol. 2012;199:723–734.10.1083/jcb.201208152
   PubMed Web of Science ®Google Scholar
• Vanier MT . Niemann-pick disease type C. Orphanet J Rare Dis. 2010;5:16.10.1186/1750-1172-5-16
   PubMed Web of Science ®Google Scholar
• Carstea ED , Morris JA , Coleman KG , et al . Niemann-pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science. 1997;277:228–231.10.1126/science.277.5323.228
   PubMed Web of Science ®Google Scholar
• Naureckiene S , Sleat DE , Lackland H , et al . Identification of HE1 as the second gene of Niemann-Pick C disease. Science. 2000;290:2298–2301.10.1126/science.290.5500.2298
   PubMed Web of Science ®Google Scholar
• Kwon HJ , Abi-Mosleh L , Wang ML , et al . Structure of N-terminal domain of npc1 reveals distinct subdomains for binding and transfer of cholesterol. Cell. 2009;137:1213–1224.10.1016/j.cell.2009.03.049
   PubMed Web of Science ®Google Scholar
• Wang ML , Motamed M , Infante RE , et al . Identification of surface residues on niemann-pick C2 essential for hydrophobic handoff of cholesterol to NPC1 in lysosomes. Cell Metab. 2010;12:166–173.10.1016/j.cmet.2010.05.016
   PubMed Web of Science ®Google Scholar
• Zervas M , Somers KL , Thrall MA , et al . Critical role for glycosphingolipids in Niemann-Pick disease type C. Curr Biol. 2001;11:1283–1287.10.1016/S0960-9822(01)00396-7
   PubMed Web of Science ®Google Scholar
• Patterson MC , Vecchio D , Prady H , et al . Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study. Lancet Neurol. 2007;6:765–772.10.1016/S1474-4422(07)70194-1
   PubMed Web of Science ®Google Scholar
• Pipalia NH , Cosner CC , Huang A , et al . Histone deacetylase inhibitor treatment dramatically reduces cholesterol accumulation in Niemann-Pick type C1 mutant human fibroblasts. Proc Natl Acad Sci USA. 2011;108:5620–5625.10.1073/pnas.1014890108
   PubMed Web of Science ®Google Scholar
• Alam MS , Getz M , Haldar K . Chronic administration of an HDAC inhibitor treats both neurological and systemic Niemann-Pick type C disease in a mouse model. Sci Transl Med. 2016;8:326ra23.10.1126/scitranslmed.aad9407
   PubMed Web of Science ®Google Scholar
• Lloyd-Evans E , Morgan AJ , He X , et al . Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium. Nat Med. 2008;14:1247–1255.10.1038/nm.1876
   PubMed Web of Science ®Google Scholar
• Liu B , Turley SD , Burns DK , et al . Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1−/− mouse. Proc Natl Acad Sci USA. 2009;106:2377–2382.10.1073/pnas.0810895106
   PubMed Web of Science ®Google Scholar
• Davidson CD , Ali NF , Micsenyi MC , et al . Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression. PLoS ONE. 2009;4:e6951.10.1371/journal.pone.0006951
   PubMed Web of Science ®Google Scholar
• Vite CH , Bagel JH , Swain GP , et al . Intracisternal cyclodextrin prevents cerebellar dysfunction and Purkinje cell death in feline Niemann-Pick type C1 disease. Sci Transl Med. 2015;7:276ra26.10.1126/scitranslmed.3010101
   PubMed Web of Science ®Google Scholar
• Tanaka Y , Ishitsuka Y , Yamada Y , et al . Influence of Npc1 genotype on the toxicity of hydroxypropyl-β-cyclodextrin, a potentially therapeutic agent, in Niemann-Pick Type C disease models. Mol Genet Metab Rep. 2014;1:19–30.10.1016/j.ymgmr.2013.12.003
   PubMedGoogle Scholar
• Soga M , Ishitsuka Y , Hamasaki M , et al . HPGCD outperforms HPBCD as a potential treatment for Niemann-Pick Disease type C during disease modeling with iPS cells. Stem Cells. 2015;33:1075–1088.10.1002/stem.1917
   PubMed Web of Science ®Google Scholar
• Muralidhar A , Borbon IA , Esharif DM , et al . Pulmonary function and pathology in hydroxypropyl-beta-cyclodextin-treated and untreated Npc1−/− mice. Mol Genet Metab. 2011;103:142–147.10.1016/j.ymgme.2011.03.001
   PubMed Web of Science ®Google Scholar
• Crumling MA , Liu L , Thomas PV , et al . Hearing loss and hair cell death in mice given the cholesterol-chelating agent hydroxypropyl-β-Cyclodextrin. PLoS ONE. 2012;7:e53280.10.1371/journal.pone.0053280
   PubMed Web of Science ®Google Scholar
• Takahashi S , Homma K , Zhou Y , et al . Susceptibility of outer hair cells to cholesterol chelator 2-hydroxypropyl-β-cyclodextrine is prestin-dependent. Sci Rep. 2016;6:21973.10.1038/srep21973
   PubMed Web of Science ®Google Scholar
• Harada A , Li J , Kamachi M . The molecular necklace: a rotaxane containing many threaded α-cyclodextrins. Nature. 1992;356:325–327.10.1038/356325a0
   Web of Science ®Google Scholar
• Harada A , Hashidzume A , Yamaguchi H , et al . Polymeric rotaxanes. Chem Rev. 2009;109:5974–6023.10.1021/cr9000622
   PubMed Web of Science ®Google Scholar
• Tamura A , Yui N . Threaded macromolecules as a versatile framework for biomaterials. Chem Commun. 2014;50:13433–13446.10.1039/C4CC03709J
   PubMed Web of Science ®Google Scholar
• Tamura A , Yui N . Lysosomal-specific cholesterol reduction by biocleavable polyrotaxanes for ameliorating Niemann-Pick type C disease. Sci Rep. 2014;4:4356.
   PubMed Web of Science ®Google Scholar
• Tamura A , Yui N . β-Cyclodextrin-threaded biocleavable polyrotaxanes ameliorate impaired autophagic flux in Niemann-Pick Type C disease. J Biol Chem. 2015;290:9442–9454.10.1074/jbc.M115.636803
   PubMed Web of Science ®Google Scholar
• Ooya T , Choi HS , Yamashita A , et al . Biocleavable polyrotaxane−plasmid DNA polyplex for enhanced gene delivery. J Am Chem Soc. 2006;128:3852–3853.10.1021/ja055868+
   PubMed Web of Science ®Google Scholar
• Watanabe J , Ooya T , Yui N . Preparation and characterization of a polyrotaxane with non-enzymatically hydrolyzable stoppers. Chem Lett. 1998;1031–1032.
   Web of Science ®Google Scholar
• Tamura A , Yui N . A supramolecular endosomal escape approach for enhancing gene silencing of siRNA using acid-degradable cationic polyrotaxanes. J Mater Chem B. 2013;1:3535–3544.10.1039/c3tb20514b
   PubMed Web of Science ®Google Scholar
• Ooya T , Ito A , Yui N . Preparation of α-cyclodextrin-terminated polyrotaxane consisting of β-cyclodextrins and pluronic as a building block of biodegradable network. Macromol Biosci. 2005;5:379–383.10.1002/(ISSN)1616-5195
   PubMed Web of Science ®Google Scholar
• Kang Y , Zhang X-M , Zhang S , et al . pH-responsive dendritic polyrotaxane drug-polymer conjugates forming nanoparticles as efficient drug delivery system for cancer therapy. Polym Chem. 2015;6:2098–2107.10.1039/C4PY01431F
   Web of Science ®Google Scholar
• Nishida K , Tamura A , Yui N . Acid-labile polyrotaxane exerting endolysosomal pH-sensitive supramolecular dissociation for therapeutic applications. Polym Chem. 2015;6:4040–4047.10.1039/C5PY00445D
   Web of Science ®Google Scholar
• Mellman I , Fuchs R , Helenius A . Acidification of the endocytic and exocytic pathways. Annu Rev Biochem. 1986;55:663–700.10.1146/annurev.bi.55.070186.003311
   PubMed Web of Science ®Google Scholar
• Elrick MJ , Yu T , Chung C , et al . Impaired proteolysis underlies autophagic dysfunction in Niemann-Pick type C disease. Hum Mol Genet. 2012;21:4876–4887.10.1093/hmg/dds324
   PubMed Web of Science ®Google Scholar
• Lafourcade C , Sobo K , Kieffer-Jaquinod S , et.al . Regulation of the V-ATPase along the endocytic pathway occurs through reversible subunit association and membrane localization. PLoS ONE. 2008;3:e2758.10.1371/journal.pone.0002758
   PubMed Web of Science ®Google Scholar
• Greene TW , Wuts PGM . Protective groups in organic synthesis, Third Edition (John Wiley & Sons); 1999
   Google Scholar
• Connors KA , Amidon GL , Stella VJ . Chemical stability of pharmaceuticals: a handbook for pharmacists (New York: Wiley); 1986
   Google Scholar
• Sugano K , Kansy M , Artursson P , et al . Coexistence of passive and carrier-mediated processes in drug transport. Nat Rev Drug Discov. 2010;9:597–614.10.1038/nrd3187
   PubMed Web of Science ®Google Scholar
• Macia E , Ehrlich M , Massol R , et al . Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell. 2006;10:839–850.10.1016/j.devcel.2006.04.002
   PubMed Web of Science ®Google Scholar
• Akiyama T , Ishida J , Nakagawa S , et al . Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem. 1987;262:5592–5595.
   PubMed Web of Science ®Google Scholar
• Pelkmans L , Püntener D , Helenius A . Local actin polymerization and dynamin recruitment in SV40-induced internalization of caveolae. Science. 2002;296:535–539.10.1126/science.1069784
   PubMed Web of Science ®Google Scholar
• Koivusalo M , Welch C , Hayashi H , et al . Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling. J Cell Biol. 2010;188:547–563.10.1083/jcb.200908086
   PubMed Web of Science ®Google Scholar
• Börnig H , Geyer G . Staining of cholesterol with the fluorescent antibiotic “filipin”. Acta Histochem. 1974;50:110–115.
   PubMed Web of Science ®Google Scholar
• Amundson DM , Zhou M . Fluorometric method for the enzymatic determination of cholesterol. J Biochem Biophys Methods. 1999;38:43–52.10.1016/S0165-022X(98)00036-0
   PubMedGoogle Scholar
• Higuchi T , Connors KA . Phase solubility techniques. Adv Anal Chem. Instrum. 1965;4:117–122.
   Google Scholar
• Brewster ME , Loftsson T . Cyclodextrins as pharmaceutical solubilizers. Adv Drug Deliv Rev. 2007;59:645–666.10.1016/j.addr.2007.05.012
   PubMed Web of Science ®Google Scholar
• Uekama K , Hirayama F , Irie T . Cyclodextrin drug carrier systems. Chem Rev. 1998;98:2045–2076.10.1021/cr970025p
   PubMed Web of Science ®Google Scholar